Convictions cleared for nearly 850K Michiganders as ‘Clean Slate’ program takes effect
The bipartisan “Clean Slate” legislation, as advocates call it, wipes clean a range of convictions from people’s records after a defined waiting period.
2023 C.E.
The world’s first rewilding center opens in Scotland
The Dundreggan Rewilding Centre in Glenmoriston offers a gateway to the U.K.’s largest nature recovery site. The 10,000-acre landscape is being nursed back to health by the charity Trees for Life, which bought the site in 2008.
New Jersey governor protects trans youth seeking health care with executive order
New Jersey Gov. Phil Murphy signed an executive order preventing people in the state from being extradited for providing, receiving, or facilitating gender-affirming care.
Cyclists now outnumber motorists in London
The number of motorists has fallen by 64% since 1999, while the number of climate-friendly cyclists has increased by 386%.
Ghana first country to approve ‘world-changer’ malaria vaccine
Malaria kills about 620,000 people each year, most of them young children. It has been a massive, century-long, scientific undertaking to develop a vaccine that protects the body from the malaria parasite.
Global wind energy to surpass 1 terawatt milestone by end of 2023
By comparison, the total installed energy capacity worldwide (including renewables and fossil fuels) is still less than 8 terawatts.
The Cook Islands decriminalize homosexuality
With the Crimes Amendment Bill, the group of 15 islands located in the South Pacific has rescinded a 1969 law that said men who have sex with men could be jailed for up to five years.
India to tender massive 50 GW of renewable energy every year for next five years
With planned tenders for 250 GW over the next five years, India’s renewable energy capacity could reach close to 550 GW by 2030. The world currently has just over 3000 GW of renewable energy capacity total.
California moves to cap insulin cost at $30 and manufacture its own naloxone
A 10-milliliter vial of insulin will be available for no more than $30, cutting costs by 90% for many.
New nuclear medicine therapy cures human non-hodgkin lymphoma in preclinical model
A single dose of this radioimmunotherapy was found to eliminate tumor cells and extend the life of mice injected with cancerous cells for more than 221 days (the trial endpoint), compared to just 19 days in untreated control mice.